Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Archer Materials ( (AU:AXE) ) has issued an update.
Archer Materials is progressing in the development of its Biochip technology with significant improvements in biosensor testing accuracy, aligning with clinical standards. The company is working on both graphene-based and silicon-based biosensor platforms, with the latter expected to facilitate quicker and more cost-effective commercialization, enhancing Archer’s market strategy and IP portfolio.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
More about Archer Materials
Archer Materials Limited is a semiconductor company focused on advancing the quantum technology and medical diagnostics industries.
YTD Price Performance: -52.59%
Average Trading Volume: 288,568
Technical Sentiment Signal: Sell
Current Market Cap: A$70.08M
For an in-depth examination of AXE stock, go to TipRanks’ Overview page.